Cabergoline: A long‐acting dopamine agonist in Parkinson's disease
- 1 October 1990
- journal article
- letter
- Published by Wiley in Annals of Neurology
- Vol. 28 (4) , 593-594
- https://doi.org/10.1002/ana.410280429
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Modification of central dopaminergic mechanisms by continuous levodopa therapy for advanced Parkinson's diseaseAnnals of Neurology, 1990
- Levodopa Consumption Reduces Dopaminergic Receptor Responsiveness in Parkinsonʼs DiseaseClinical Neuropharmacology, 1989
- Continuous Dopaminergic Stimulation in Parkinson's DiseaseCanadian Journal of Neurological Sciences, 1987
- Long-Lasting Prolactin-Lowering Effect of Cabergoline, A New Dopamine Agonist, in Hyperprolactinemic PatientsJournal of Clinical Endocrinology & Metabolism, 1986